| P50 | author | C Michael Hart | Q92643656 |
| P2093 | author name string | David E Green | |
| | Bum-Yong Kang | |
| | Charles D Searles | |
| | Tamara C Murphy | |
| P2860 | cites work | Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 |
| | miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism | Q24316257 |
| | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway | Q28115005 |
| | SMAD proteins control DROSHA-mediated microRNA maturation | Q28941771 |
| | Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension | Q33593476 |
| | Effects of PPAR gamma ligands on TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells. | Q33748854 |
| | Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies | Q33849207 |
| | Hypoxia mediates mutual repression between microRNA-27a and PPARγ in the pulmonary vasculature | Q42593185 |
| | Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats | Q43024791 |
| | MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity | Q43083934 |
| | Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation | Q43182141 |
| | Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. | Q43621579 |
| | Effects of peroxisome proliferator-activated receptor gamma ligands on monocrotaline-induced pulmonary hypertension in rats | Q46558968 |
| | Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms | Q46601702 |
| | Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. | Q51763432 |
| | Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats. | Q53723593 |
| | Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. | Q54312871 |
| | Peroxisome Proliferator-Activated Receptor-γ Ameliorates Pulmonary Arterial Hypertension by Inhibiting 5-Hydroxytryptamine 2B Receptor | Q58335888 |
| | A Role for miR-145 in Pulmonary Arterial Hypertension | Q63916426 |
| | Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling | Q79451455 |
| | microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma | Q84623574 |
| | miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis | Q34044475 |
| | PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B. | Q34212735 |
| | BMP-2 up-regulates PTEN expression and induces apoptosis of pulmonary artery smooth muscle cells under hypoxia | Q34277172 |
| | The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation | Q34294854 |
| | MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration | Q34426103 |
| | miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression | Q34528510 |
| | An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension | Q34589929 |
| | Role for miR-204 in human pulmonary arterial hypertension | Q34681312 |
| | Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension? | Q34897476 |
| | The microRNA-130/301 family controls vasoconstriction in pulmonary hypertension | Q35002833 |
| | Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation | Q35085751 |
| | Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival | Q35187029 |
| | MicroRNAs in pulmonary arterial hypertension | Q35207669 |
| | Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling | Q35601455 |
| | miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. | Q35850316 |
| | The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study | Q36001145 |
| | Peroxisome proliferator-activated receptor gamma (PPARγ) regulates thrombospondin-1 and Nox4 expression in hypoxia-induced human pulmonary artery smooth muscle cell proliferation | Q36563581 |
| | MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. | Q36673482 |
| | Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology | Q36701812 |
| | Molecular pathogenesis of pulmonary arterial hypertension | Q36736065 |
| | New insights into PTEN. | Q37011116 |
| | Understanding PTEN regulation: PIP2, polarity and protein stability | Q37270444 |
| | PPARgamma as a potential therapeutic target in pulmonary hypertension | Q37689190 |
| | PPARgamma and the pathobiology of pulmonary arterial hypertension | Q37702992 |
| | Emerging therapies for the treatment of pulmonary hypertension | Q37705888 |
| | miRNAs: roles and clinical applications in vascular disease | Q37822463 |
| | Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells | Q39150404 |
| | MicroRNAs-control of essential genes: Implications for pulmonary vascular disease. | Q39385085 |
| | Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1. | Q39535578 |
| | The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo | Q39684983 |
| | Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model | Q39879690 |
| | Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension | Q40036197 |
| | Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth | Q40652271 |
| | MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation | Q41166615 |
| | Dysregulation of PTEN in cardiopulmonary vascular remodeling induced by pulmonary hypertension. | Q41170725 |
| | Holding our breath: The emerging and anticipated roles of microRNA in pulmonary hypertension | Q41546903 |
| | Selective inactivation of PTEN in smooth muscle cells synergizes with hypoxia to induce severe pulmonary hypertension | Q41827194 |
| | MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach | Q42172409 |
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| | microRNA | Q310899 |
| | Phosphatase and tensin homolog | Q416356 |
| | negative regulation of vascular associated smooth muscle cell proliferation | Q22304651 |
| P304 | page(s) | e0133391 | |
| P577 | publication date | 2015-07-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21. | |
| P478 | volume | 10 | |